Total Medical devices industry cross border deals worth $2.6bn were announced globally for July 2022, with the $1.54bn private equity deal with Meridian Bioscience being the sector’s biggest investment, according to GlobalData’s deals database.
- Embed this chart
Embed this chart into your website
Copy and paste the image source into your website to display the chart.
The value marked a decrease of 17.8% over the previous month of $3.14bn and a drop of 28.3% when compared with the last 12-month average of $3.6bn.
In terms of number of cross border deals, the sector saw a drop of 18.64% with 48 deals in July 2022 when compared to the last 12-month average of 59 deals.
In value terms, North America led the activity with cross border deals worth $2.23bn in July 2022.
Medical devices industry cross border deals in July 2022: Top deals
The top five cross border deals accounted for 82.2% of the overall value during July 2022.
The combined value of the top five cross border deals stood at $2.12bn, against the overall value of $2.6bn recorded for the month.
The top five Medical devices industry cross border deals of July 2022 tracked by GlobalData were:
1) SD Biosensor and SJL Partners $1.54bn private equity deal with Meridian Bioscience
2) The $223m venture financing of Cleerly by Breyer Capital,Cigna Ventures,DigiTx Partners,Fidelity Management & Research,Heartland Healthcare Capital,LRVHealth,Mirae Asset Capital,New Leaf Ventures,Novartis,Peter Thiel,Piper Sandler Merchant Banking,Sands Capital Management,T Rowe Price Associates,T. Rowe Price Investment Management and Vensana Capital
3) Peninsula Capital Partners $143.03m private equity deal with Red Kiwi
4) The $110m venture financing of Orchestra BioMed by Medtronic,Perceptive Advisors,RTW Investments,SternAegis Ventures and Terumo
5) Emerson Collective (Emmerson Collective) and KIRKBI Invest $100m venture financing deal with Kerecis ehf